Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon

New campaign to enroll more young people on ACA exchanges

Following up on plans HHS announced in June, CMS has outlined additional recruitment efforts to attract younger, healthier enrollees on the Affordable Care Act (ACA) exchanges to improve the risk pool.

FTC loss on blocking Hershey-Pinnacle hospital merger reversed on appeal

The merger of Penn State Hershey Medical Center and Pinnacle Health System in Pennsylvania can be blocked by the Federal Trade Commission, according to a ruling by a federal appeals court judge, reversing a decision in May that went against the FTC.

FDA approves drug biosimilar to Humira

The FDA approved a new drug called Amjevita Sept. 23. The drug, adalimumab-atto, is made by the California-based company Amgen and is biosimilar to the AbbVie drug Humira (adalimumab). 

Sylvia Burwell discusses ACA, provider success on podcast

Health and Human Services (HHS) Secretary Sylvia Burwell doesn’t have much time left in her position. Her boss’s second presidential term is almost over, so her role as steward of his hallmark policy, the Affordable Care Act (ACA), will be over too. 

Last-minute exchange decisions: Nebraska loses BCBS, Highmark stays in 3 states

Sept. 23 was the final day for insurers to confirm their health insurance exchange participation in the states relying on the federal Healthcare.gov marketplace. Last-minute decisions by two insurers will affect coverage options in Delaware, Nebraska, Pennsylvania and West Virginia. 

Trump falsely claims ACA open enrollment could be delayed

Donald Trump has been telling supporters and reporters that President Barack Obama is trying to delay open enrollment on health insurance exchanges until after Election Day—but the start date has been set in stone for months.

Medicare Advantage premiums will drop slightly for 2017

The average monthly premium for Medicare Advantage enrollees will drop about 4 percent, or $1.19, to $31.40, according to a new estimate released by CMS.

How the presidential race could affect uninsured rates, out-of-pocket costs

The state of health care would look dramatically different under a Hillary Clinton presidency than it would under Donald Trump, according to a new report from the Commonwealth Fund and the RAND Corporation.

Displaying 2249 - 2256 of 2769

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup